Common Contracts
5 similar Equity Transfer Agreement contracts by Yew Bio-Pharm Group, Inc.
Harbin Yew Science and Technology Development Co., Ltd. Equity Transfer AgreementEquity Transfer Agreement • May 8th, 2012 • Yew Bio-Pharm Group, Inc.
The registered capital of Harbin Yew Science and Technology Development Co., Ltd (hereinafter referred to as the “Target Company”) is RMB 45,000,000, among which, Party A’s capital contribution is RMB 8,340,000 and accounts for 18.53% of the total share capital. In accordance with relevant laws and regulations, the Parties reach the following agreement through negotiation in good faith:
Harbin Yew Science and Technology Development Co., Ltd. Equity Transfer AgreementEquity Transfer Agreement • May 8th, 2012 • Yew Bio-Pharm Group, Inc.
The registered capital of Harbin Yew Science and Technology Development Co., Ltd (hereinafter referred to as the “Target Company”) is RMB 45,000,000, among which, Party A’s capital contribution is RMB 1,450,000 and accounts for 3.22% of the total share capital. In accordance with relevant laws and regulations, the Parties reach the following agreement through negotiation in good faith:
Harbin Yew Science and Technology Development Co., Ltd. Equity Transfer AgreementEquity Transfer Agreement • May 8th, 2012 • Yew Bio-Pharm Group, Inc.
The registered capital of Harbin Yew Science and Technology Development Co., Ltd (hereinafter referred to as the “Target Company”) is RMB 45,000,000, among which, Party A’s capital contribution is RMB 4,780,000 and accounts for 10.62% of the total share capital. In accordance with relevant laws and regulations, the Parties reach the following agreement through negotiation in good faith:
Harbin Yew Science and Technology Development Co., Ltd. Equity Transfer AgreementEquity Transfer Agreement • May 8th, 2012 • Yew Bio-Pharm Group, Inc.
The registered capital of Harbin Yew Science and Technology Development Co., Ltd (hereinafter referred to as the “Target Company”) is RMB 45,000,000, among which, Party A’s capital contribution is RMB 2,170,000 and accounts for 4.82% of the total share capital. In accordance with relevant laws and regulations, the Parties reach the following agreement through negotiation in good faith:
Harbin Yew Science and Technology Development Co., Ltd. Equity Transfer AgreementEquity Transfer Agreement • May 8th, 2012 • Yew Bio-Pharm Group, Inc.
The registered capital of Harbin Yew Science and Technology Development Co., Ltd (hereinafter referred to as the “Target Company”) is RMB 45,000,000, among which, Party A’s capital contribution is RMB 28,260,000 and accounts for 62.8% of the total share capital. In accordance with relevant laws and regulations, the Parties reach the following agreement through negotiation in good faith:
